アナリストが価格目標を引き上げると、Cencora の株価は上昇し、同社は配当を 12.67% 増配します。 Cencora's stock rises as analysts raise price targets, and the company boosts its dividend by 12.67%.
医薬品流通会社のCencola は、複数のアナリストが目標株価を引き上げた後、株価が上昇しました。 Cencora, a pharmaceutical distribution company, saw its shares rise after several analysts raised their price targets. 会社は四半期配当を0.55ドルで 12.67%増と発表し,株は"適度な買い"のコンセンサス評価を持っています. The company declared a $0.55 quarterly dividend, up 12.67%, and the stock has a "Moderate Buy" consensus rating. 機関投資家は,Versor Investments LPを含む,積極的に株式を購入しています. Institutional investors, including Versor Investments LP, are actively buying shares. CencoraのCEOは最近、かなりの量の株式を売却しましたが、同社の時価総額は490億5000万ドルで、PERは33.08です。 Cencora's CEO sold a significant amount of stock recently, while the company's market cap is $49.05 billion with a P/E ratio of 33.08.